Matthew Ros - Executive Vice President, Chief Strategy & Business Officer at Epizyme, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Matthew Ros since 13 Sep 2025

Reported holdings for Matthew Ros in Epizyme, Inc.

Form 4 holding Executive Vice President, Chief Strategy & Business Officer

Epizyme, Inc.

Security class
Common Stock, par value $0.0001
Shares / value
111,313
Estimated value
$156,951
Report date
16 Aug 2021
Price
$1.41
Ownership
Direct
Form 4 holding Executive Vice President, Chief Strategy & Business Officer

Epizyme, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
134,178
Estimated value
Report date
16 Aug 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Matthew Ros in Epizyme, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .